SDC1 and Burkitt lymphoma: Immunoblastic DLBCL and BL can be excluded on the basis of the characteristic immunophenotypic pattern of PBL with CD20 negativity in combination with positive markers of postgerminal center B-cells and plasma cells, such as CD138/syndecan [1, 9].